249 related articles for article (PubMed ID: 24157709)
1. Differential regulation of the REGγ-proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells.
Ali A; Wang Z; Fu J; Ji L; Liu J; Li L; Wang H; Chen J; Caulin C; Myers JN; Zhang P; Xiao J; Zhang B; Li X
Nat Commun; 2013; 4():2667. PubMed ID: 24157709
[TBL] [Abstract][Full Text] [Related]
2. Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ.
Wang H; Bao W; Jiang F; Che Q; Chen Z; Wang F; Tong H; Dai C; He X; Liao Y; Liu B; Sun J; Wan X
Cancer Lett; 2015 May; 360(2):269-79. PubMed ID: 25697482
[TBL] [Abstract][Full Text] [Related]
3. The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells.
Gao X; Wang Q; Wang Y; Liu J; Liu S; Liu J; Zhou X; Zhou L; Chen H; Pan L; Chen J; Wang D; Zhang Q; Shen S; Xiao Y; Wu Z; Cheng Y; Chen G; Kubra S; Qin J; Huang L; Zhang P; Wang C; Moses RE; Lonard DM; Malley BWO; Fares F; Zhang B; Li X; Li L; Xiao J
Nat Commun; 2020 Aug; 11(1):3904. PubMed ID: 32764536
[TBL] [Abstract][Full Text] [Related]
4. REGgamma modulates p53 activity by regulating its cellular localization.
Liu J; Yu G; Zhao Y; Zhao D; Wang Y; Wang L; Liu J; Li L; Zeng Y; Dang Y; Wang C; Gao G; Long W; Lonard DM; Qiao S; Tsai MJ; Zhang B; Luo H; Li X
J Cell Sci; 2010 Dec; 123(Pt 23):4076-84. PubMed ID: 21084564
[TBL] [Abstract][Full Text] [Related]
5. The REGγ-Proteasome Regulates Spermatogenesis Partially by P53-PLZF Signaling.
Gao X; Chen H; Liu J; Shen S; Wang Q; Clement TM; Deskin BJ; Chen C; Zhao D; Wang L; Guo L; Ma X; Zhang B; Xu Y; Li X; Li L
Stem Cell Reports; 2019 Sep; 13(3):559-571. PubMed ID: 31402338
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway.
Li X; Amazit L; Long W; Lonard DM; Monaco JJ; O'Malley BW
Mol Cell; 2007 Jun; 26(6):831-42. PubMed ID: 17588518
[TBL] [Abstract][Full Text] [Related]
7. Oxidative challenge enhances REGγ-proteasome-dependent protein degradation.
Zhang Y; Liu S; Zuo Q; Wu L; Ji L; Zhai W; Xiao J; Chen J; Li X
Free Radic Biol Med; 2015 May; 82():42-9. PubMed ID: 25656993
[TBL] [Abstract][Full Text] [Related]
8. REGgamma, a proteasome activator and beyond?
Mao I; Liu J; Li X; Luo H
Cell Mol Life Sci; 2008 Dec; 65(24):3971-80. PubMed ID: 18679578
[TBL] [Abstract][Full Text] [Related]
9. Site-specific acetylation of the proteasome activator REGγ directs its heptameric structure and functions.
Liu J; Wang Y; Li L; Zhou L; Wei H; Zhou Q; Liu J; Wang W; Ji L; Shan P; Wang Y; Yang Y; Jung SY; Zhang P; Wang C; Long W; Zhang B; Li X
J Biol Chem; 2013 Jun; 288(23):16567-16578. PubMed ID: 23612972
[TBL] [Abstract][Full Text] [Related]
10. Proteasome activator REGgamma enhances coxsackieviral infection by facilitating p53 degradation.
Gao G; Wong J; Zhang J; Mao I; Shravah J; Wu Y; Xiao A; Li X; Luo H
J Virol; 2010 Nov; 84(21):11056-66. PubMed ID: 20719955
[TBL] [Abstract][Full Text] [Related]
11. REGγ potentiates TGF-β/Smad signal dependent epithelial-mesenchymal transition in thyroid cancer cells.
Bhatti MZ; Pan L; Wang T; Shi P; Li L
Cell Signal; 2019 Dec; 64():109412. PubMed ID: 31491459
[TBL] [Abstract][Full Text] [Related]
12. REGγ deficiency promotes premature aging via the casein kinase 1 pathway.
Li L; Zhao D; Wei H; Yao L; Dang Y; Amjad A; Xu J; Liu J; Guo L; Li D; Li Z; Zuo D; Zhang Y; Liu J; Huang S; Jia C; Wang L; Wang Y; Xie Y; Luo J; Zhang B; Luo H; Donehower LA; Moses RE; Xiao J; O'Malley BW; Li X
Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11005-10. PubMed ID: 23766372
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor p53 abrogates Smad-dependent collagen gene induction in mesenchymal cells.
Ghosh AK; Bhattacharyya S; Varga J
J Biol Chem; 2004 Nov; 279(46):47455-63. PubMed ID: 15345715
[TBL] [Abstract][Full Text] [Related]
14. REGgamma proteasome activator is involved in the maintenance of chromosomal stability.
Zannini L; Lecis D; Buscemi G; Carlessi L; Gasparini P; Fontanella E; Lisanti S; Barton L; Delia D
Cell Cycle; 2008 Feb; 7(4):504-12. PubMed ID: 18235248
[TBL] [Abstract][Full Text] [Related]
15. REGγ accelerates melanoma formation by regulating Wnt/β-catenin signalling pathway.
Chen H; Gao X; Sun Z; Wang Q; Zuo D; Pan L; Li K; Chen J; Chen G; Hu K; Li K; Shah AS; Huang T; Muhammad Zeeshan B; Tong L; Jiao C; Liu J; Chen T; Yao L; Dang Y; Liu T; Li L
Exp Dermatol; 2017 Nov; 26(11):1118-1124. PubMed ID: 28605165
[TBL] [Abstract][Full Text] [Related]
16. Mutant p53 promotes tumor cell malignancy by both positive and negative regulation of the transforming growth factor β (TGF-β) pathway.
Ji L; Xu J; Liu J; Amjad A; Zhang K; Liu Q; Zhou L; Xiao J; Li X
J Biol Chem; 2015 May; 290(18):11729-40. PubMed ID: 25767119
[TBL] [Abstract][Full Text] [Related]
17. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome.
Li X; Lonard DM; Jung SY; Malovannaya A; Feng Q; Qin J; Tsai SY; Tsai MJ; O'Malley BW
Cell; 2006 Jan; 124(2):381-92. PubMed ID: 16439211
[TBL] [Abstract][Full Text] [Related]
18. REGγ ablation impedes dedifferentiation of anaplastic thyroid carcinoma and accentuates radio-therapeutic response by regulating the Smad7-TGF-β pathway.
Jiao C; Li L; Zhang P; Zhang L; Li K; Fang R; Yuan L; Shi K; Pan L; Guo Q; Gao X; Chen G; Xu S; Wang Q; Zuo D; Wu W; Qiao S; Wang X; Moses R; Xiao J; Li L; Dang Y; Li X
Cell Death Differ; 2020 Feb; 27(2):497-508. PubMed ID: 31243343
[TBL] [Abstract][Full Text] [Related]
19. REGγ is critical for skin carcinogenesis by modulating the Wnt/β-catenin pathway.
Li L; Dang Y; Zhang J; Yan W; Zhai W; Chen H; Li K; Tong L; Gao X; Amjad A; Ji L; Jing T; Jiang Z; Shi K; Yao L; Song D; Liu T; Yang X; Yang C; Cai X; Xu W; Huang Q; He J; Liu J; Chen T; Moses RE; Fu J; Xiao J; Li X
Nat Commun; 2015 Apr; 6():6875. PubMed ID: 25908095
[TBL] [Abstract][Full Text] [Related]
20. REGγ deficiency suppresses tumor progression via stabilizing CK1ε in renal cell carcinoma.
Chen S; Wang Q; Wang L; Chen H; Gao X; Gong D; Ma J; Kubra S; Yao X; Li X; Li L; Zhai W; Zheng J
Cell Death Dis; 2018 May; 9(6):627. PubMed ID: 29795381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
